Government approved Sputnik-V vaccine in India
Read Time:50 Second
The government on Monday approved Sputnik-V, the vaccine against the coronavirus disease (Covid-19) developed by Russia. This is the third vaccine approved by India after Covishield and Covaxin.
Dr Reddy’s Laboratories, the Hyderabad-based pharmaceutical company, last week sought the government’s approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy’s in September 2020 to conduct clinical trials of Sputnik V in India. The Russian vaccine has an efficacy of 91.6% and is conducting its Phase III clinical trials in the UAE, India, Venezuela and Belarus, according to the Sputnik-V’s website.
Along with Dr Reddy’s the RDIF partnered with Virchow Biotech Private Limited in March to produce up to 200 million doses per year of Sputnik V in India. It has also partnered with Stelis Biopharma Pvt Ltd and Panacea Biotec earlier in April as well to produce 200 million and 100 million doses per year of Sputnik V in the country.
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
More Stories
Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate Injection USP.
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for...
Alembic reports 11% growth in revenue for Q4 FY22 from INR 1280 Cr. in FY21 to INR 1416 Cr.
Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 31st March 2022. Financial HighlightsIndia Branded Business up...
Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam.
Alembic Pharmaceuticals Limited (Alembic) today announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the...
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.Alembic Pharmaceuticals Limited (Alembic) today announced that...
Covishield &Covaxin prices slashed to Rs.225 from Rs.1200 and Rs.600
Vaccine makers Serum Institute of India and Bharat Biotech have reduced the price of coronavirus vaccines Covishield and Covaxin to...
23lac blessings saved 96% lung damaged mother of twin toddlers at Vadodara.
This is not just another Covid Survival story, but this is story of a movement which connected unknown people with...
Average Rating